These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25636301)

  • 21. Sustained release of calcium hydroxide from poly(DL-lactide-co-glycolide) acid microspheres for apexification.
    Cerda-Cristerna BI; Breceda-Leija A; Méndez-González V; Chavarría-Bolaños D; Flores-Reyes H; Garrocho-Rangel A; Komabayashi T; Wadajkar AS; Pozos-Guillén AJ
    Odontology; 2016 Sep; 104(3):318-23. PubMed ID: 26175086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and characteristics of interferon-alpha poly(lactic-co-glycolic acid) microspheres.
    Yang F; Song FL; Pan YF; Wang ZY; Yang YQ; Zhao YM; Liang SZ; Zhang YM
    J Microencapsul; 2010; 27(2):133-41. PubMed ID: 20121486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Particle Size on Drug Loading and Release Kinetics of Gefitinib-Loaded PLGA Microspheres.
    Chen W; Palazzo A; Hennink WE; Kok RJ
    Mol Pharm; 2017 Feb; 14(2):459-467. PubMed ID: 27973854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel hemostatic delivery device for thrombin: biodegradable poly(D,L-lactide-co-glycolide) 50:50 microspheres.
    Smeets R; Gerhards F; Stein JM; Paz RM; Vogt S; Pautke C; Weitz J; Kolk A
    J Biomed Mater Res A; 2011 Jan; 96(1):177-85. PubMed ID: 21105166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computer modeling assisted design of monodisperse PLGA microspheres with controlled porosity affords zero order release of an encapsulated macromolecule for 3 months.
    Kazazi-Hyseni F; Landin M; Lathuile A; Veldhuis GJ; Rahimian S; Hennink WE; Kok RJ; van Nostrum CF
    Pharm Res; 2014 Oct; 31(10):2844-56. PubMed ID: 24825756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained release of risperidone from biodegradable microspheres prepared by in-situ suspension-evaporation process.
    An T; Choi J; Kim A; Lee JH; Nam Y; Park J; Sun Bk; Suh H; Kim CJ; Hwang SJ
    Int J Pharm; 2016 Apr; 503(1-2):8-15. PubMed ID: 26899975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sunitinib microspheres based on [PDLLA-PEG-PDLLA]-b-PLLA multi-block copolymers for ocular drug delivery.
    Ramazani F; Hiemstra C; Steendam R; Kazazi-Hyseni F; Van Nostrum CF; Storm G; Kiessling F; Lammers T; Hennink WE; Kok RJ
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):368-77. PubMed ID: 25701807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S; Janoria KG; Mitra AK
    J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: In-vitro characterization and in-vivo pharmacokinetic studies.
    Vora L; V G S; Vavia P
    Eur J Pharm Sci; 2017 Sep; 107():78-86. PubMed ID: 28629804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
    Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX
    Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A sulfate polysaccharide/TNF-related apoptosis-inducing ligand (TRAIL) complex for the long-term delivery of TRAIL in poly(lactic-co-glycolic acid) (PLGA) microspheres.
    Kim H; Jeong D; Kang HE; Lee KC; Na K
    J Pharm Pharmacol; 2013 Jan; 65(1):11-21. PubMed ID: 23215683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Injectable Sustained-Release Depots of PLGA Microspheres for Insoluble Drugs Prepared by hot-Melt Extrusion.
    Guo Y; Yang Y; He L; Sun R; Pu C; Xie B; He H; Zhang Y; Yin T; Wang Y; Tang X
    Pharm Res; 2017 Oct; 34(10):2211-2222. PubMed ID: 28741064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administration.
    Rodríguez Villanueva J; Bravo-Osuna I; Herrero-Vanrell R; Molina Martínez IT; Guzmán Navarro M
    Eur J Pharm Sci; 2016 Sep; 92():287-97. PubMed ID: 26987610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH; Park TG
    Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PLGA microdevices for retinoids sustained release produced by supercritical emulsion extraction: continuous versus batch operation layouts.
    Porta GD; Campardelli R; Falco N; Reverchon E
    J Pharm Sci; 2011 Oct; 100(10):4357-67. PubMed ID: 21638283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A potential approach for decreasing the burst effect of protein from PLGA microspheres.
    Fu K; Harrell R; Zinski K; Um C; Jaklenec A; Frazier J; Lotan N; Burke P; Klibanov AM; Langer R
    J Pharm Sci; 2003 Aug; 92(8):1582-91. PubMed ID: 12884245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release.
    Liang D; Frank S; Schwendeman SP
    Drug Deliv Transl Res; 2024 Mar; 14(3):696-704. PubMed ID: 38038895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced targeting efficiency of PLGA microspheres loaded with Lornoxicam for intra-articular administration.
    Zhang Z; Bi X; Li H; Huang G
    Drug Deliv; 2011; 18(7):536-44. PubMed ID: 21812757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
    Bae SE; Son JS; Park K; Han DK
    J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.